Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sodium acid phosphate 1.72g suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
Product containing monobasic sodium phosphate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
Product containing only methenamine mandelate 500 mg and sodium acid phosphate 500 mg/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
Product containing monobasic sodium phosphate and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Sodium acid phosphate + sodium phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
Product containing precisely monobasic sodium phosphate 1.5 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
Product containing methenamine mandelate and sodium phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
Sodium acid phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
phosphate monosodique monohydrate |
Is a |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
sodio fosfato monobasico diidrato |
Is a |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
2 |
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
2 |
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Product containing only methenamine mandelate 500 mg and sodium acid phosphate 500 mg/1 each oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Product containing only methenamine mandelate 500 mg and sodium acid phosphate 500 mg/1 each oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Product containing precisely monobasic sodium phosphate 1.5 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Product containing precisely monobasic sodium phosphate 1.5 gram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Monobasic sodium phosphate monohydrate (substance) |
Is a |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
Product containing methenamine and monobasic sodium phosphate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Monobasic sodium phosphate monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
phosphate monosodique monohydrate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
sodio fosfato monobasico diidrato |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
Product containing precisely monobasic sodium phosphate 1.5 gram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
2 |
Monobasic sodium phosphate dodecahydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Monobasic sodium phosphate |
Inferred relationship |
Some |
2 |
Monobasic sodium phosphate dihydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
Monobasic sodium phosphate anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
|
Product containing monobasic sodium phosphate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Product containing methenamine and monobasic sodium phosphate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Product containing only monobasic sodium phosphate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Product containing only monobasic sodium phosphate and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Product containing only methenamine and monobasic sodium phosphate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Methenamine and monobasic sodium phosphate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Monobasic sodium phosphate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Dibasic sodium phosphate 240 microgram/mL and monobasic sodium phosphate 542 microgram/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Dibasic sodium phosphate 240 microgram/mL and monobasic sodium phosphate 542 microgram/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Dibasic sodium phosphate and monobasic sodium phosphate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Product containing dibasic sodium phosphate and monobasic sodium phosphate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Dibasic sodium phosphate and monobasic sodium phosphate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |
Dibasic sodium phosphate- and monobasic sodium phosphate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Monobasic sodium phosphate |
Inferred relationship |
Some |
1 |